Identifying elevated risk for future pain crises in sickle-cell disease using photoplethysmogram patterns measured during sleep: A machine learning approach
Source check: Source checked. Not independent scientific confirmation.
Finding: Sleep heart-rate/PPG models predict future vaso-occlusive pain crises in children/adolescents with sickle-cell disease; a stacked model and cross-validation are evaluated against a random baseline. Scope is exploratory home-monitoring risk prediction, not clinical outcome prevention. Methods describes 252 SCD subjects, feature selection, cross-validation and held-out prediction against baseline; retrospective cohort caveats retained.
Technology: Stacked ML classifiers use overnight heart-rate and photoplethysmogram features to predict subsequent VOC pain crises.
Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.
- AI contribution
- Stacked ML classifiers use overnight heart-rate and photoplethysmogram features to predict subsequent VOC pain crises.
- Test and result
- Sleep heart-rate/PPG models predict future vaso-occlusive pain crises in children/adolescents with sickle-cell disease; a stacked model and cross-validation are evaluated against a random baseline. Scope is exploratory home-monitoring risk prediction, not clinical outcome prevention.
- Limitation / still unknown
- Methods describes 252 SCD subjects, feature selection, cross-validation and held-out prediction against baseline; retrospective cohort caveats retained. The source does not establish benefits beyond the reported evaluation.
Evidence sources and annotation context
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
Evidence sources: https://www.frontiersin.org/journals/digital-health/articles/10.3389/fdgth.2021.714741/full
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: other. Paper: not linked in this catalog; this does not mean no paper exists.
Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..
No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.
Editorial assessment: Impact 2/5 · Validation 2/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.